P&G Hygiene and Health Care Q2 EBITDA falls 8.8% to ₹260 crore
In short
Procter & Gamble Hygiene and Health Care reported Q2 EBITDA of ₹260 crore, down 8.8% from ₹285 crore a year ago. Its EBITDA margin also fell to 22.7% from 24.8%.
The lower profit and thinner margin were a weak sign for the company’s quarterly performance and helped pressure the stock.
What the reporting says
Procter & Gamble Hygiene and Health Care reported Q2 EBITDA of ₹260 crore, down 8.8% from ₹285 crore a year earlier, according to a CNBC TV18 Market summary. Its EBITDA margin also slipped to 22.7% from 24.8% in the prior-year period. The weaker margin and profit measure were cited in market reaction to the results.
Why it matters
Procter & Gamble Hygiene and Health Care reported weaker Q2 operating performance, with EBITDA falling to ₹260 crore from ₹285 crore and the EBITDA margin narrowing to 22.7% from 24.8%. The figures suggest lower profitability in the quarter and were followed by a stock decline, according to the market summary.